Ashwani Singal

Associate Professor of Medicine and Director Hepatology Elective Course

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ashwani Singal is an Associate Professor of Medicine and the Director of the Hepatology Elective Course at the University of South Dakota Sanford School of Medicine and Avera Transplant Institute. His research primarily focuses on alcohol-associated liver disease, including mortality trends, disparities in liver listings and transplants, and public health policies aimed at prevention. Recent contributions include meta-analyses on treatment outcomes in alcohol-associated hepatitis and investigations into the characteristics of liver transplant candidates in the United States.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Lorenzo Leggio

UNITED STATES

View details

Aparna Goel

Assistant Clinical Professor

Stanford University School of Medicine

UNITED STATES

View details

Anji Wall

Baylor University Medical Center

UNITED STATES

View details

Mohamed Elfeki

Assistant Professor

South Dakota State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ashwani Singal

Research Interests

Explore related searches

Contact this professor

About

Articles (29)

Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis

Delisting From Liver Transplant List for Improvement and Recompensation Among Decompensated Patients at One Year

Increasing Trends on Intercostal Chest Tube Placement for Hepatic Hydrothorax Despite Negative Impact on Patient Outcomes: A National Inpatient Sample Database Analysis

Sex and Race Disparities in Liver Listings and Transplants in the United States

Biomarker to Predict Infection and Optimize Antibiotics Use in Patients With Acutely Decompensated Cirrhosis: A Step in the Right Direction

Public health policies to prevent alcohol-related liver disease

Short-Term and Long-Term Outcomes Among a National Cohort of US Veterans Hospitalized for Alcohol-Associated Hepatitis

Differential candidate characteristics associated with increasing ALD and MASH among liver transplant listings in the US

Metabolic Dysfunction and Alcohol-Associated Liver Disease: A Narrative Review

Treatment of alcohol use disorder in alcohol-associated liver disease: A meta-analysis

Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis

Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin

Response to comments on ‘Changing landscape of alcohol‐associated liver disease in younger individuals, women and ethnic minorities’

Changing landscape of alcohol‐associated liver disease in younger individuals, women, and ethnic minorities

Emerging targets for therapy in ALD: Lessons from NASH

Positive phosphatidyl-ethanol test in liver disease patients: You can't handle the truth!

Waitlist and posttransplant outcomes of pregnancy-related acute liver failure in the United States

An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study

Clinical criteria accurately diagnose severe but not moderate alcohol-associated hepatitis: A systematic review and meta-analysis

Waitlist and post‐transplant outcomes among candidates listed for liver transplant: Liver alone versus simultaneous liver kidney listings

Global burden of cirrhosis and liver cancer due to alcohol: the past, present, and the future

Editorial: The US burden of HRS‐AKI—Putting numbers to the problem: Authors' reply

Integrated Multidisciplinary Management of Alcohol-Associated Liver Disease

Editorial: mitochondrial respiratory chain activity—a potential link with disease severity and treatment response in alcoholic hepatitis

Nomogram model for hospitalized patients in the ICU for alcohol-related cirrhosis: A step closer to the continuing search for an ideal prognostic model

Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations

Possible link between higher ammonia levels, non-alcoholic fatty liver-related cirrhosis and diabetes: Are we missing chronic kidney disease?

Therapeutic targets in alcohol-associated liver disease: progress and challenges

Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies

Collaborators (4)

Lorenzo Leggio

Aparna Goel

Anji Wall

Mohamed Elfeki

Make your next move.